Sale!

COG1 Gene Glycosylation Disorder Type 2G Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “COG1 Gene Glycosylation Disorder Type 2G Genetic Test” is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COG1 gene, which are associated with Congenital Disorders of Glycosylation (CDG) Type 2G. These disorders are a group of rare genetic conditions that affect the normal process of adding sugar chains to proteins (glycosylation), which is crucial for proper protein function and cellular operations. Mutations in the COG1 gene can lead to various symptoms, including developmental delays, neurological issues, and abnormalities in organ function.

The test is particularly valuable for individuals showing symptoms suggestive of CDG Type 2G, families with a history of the condition, or healthcare providers seeking a diagnosis for their patients presenting with related symptoms. Performed at the state-of-the-art facilities of DNA Labs UAE, the test involves analyzing the patient’s DNA to look for specific genetic alterations in the COG1 gene that confirm the diagnosis of CDG Type 2G.

The cost of the COG1 Gene Glycosylation Disorder Type 2G Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to identify the genetic mutation responsible for the disorder, offering crucial information that can guide treatment decisions, management plans, and provide insight into the prognosis of the condition. Additionally, the results can have significant implications for family planning and the genetic counseling of affected families, helping them understand the risks of the disorder being passed on to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COG1 Gene Glycosylation disorder type 2G Genetic Test

At DNA Labs UAE, we offer the COG1 Gene Glycosylation disorder type 2G Genetic Test to help diagnose individuals with suspected glycosylation disorders. This genetic test detects mutations or variations in the COG1 gene, which is responsible for the production of a protein involved in the glycosylation process.

Test Details

The COG1 gene glycosylation disorder type 2G NGS genetic test uses Next-Generation Sequencing (NGS) technology to analyze the entire coding region of the COG1 gene. This allows for the simultaneous analysis of multiple genes and provides a comprehensive evaluation of genetic variations or mutations.

Glycosylation is a crucial process in which sugar molecules are attached to proteins or lipids, forming glycoproteins or glycolipids. It plays a vital role in various cellular processes, including cell signaling, protein folding, and cell adhesion. Mutations in the COG1 gene can disrupt the glycosylation process, leading to the development of glycosylation disorder type 2G.

Symptoms and Diagnosis

Glycosylation disorder type 2G can cause a wide range of symptoms, including developmental delays, intellectual disabilities, skeletal abnormalities, and organ dysfunction. To diagnose this disorder, a clinical history of the patient is taken, and a genetic counseling session is conducted to draw a pedigree chart of family members affected by glycosylation disorder type 2G.

Test Components and Price

The COG1 Gene Glycosylation disorder type 2G Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Test Department

After the sample is collected, the report will be delivered within 3 to 4 weeks. The COG1 Gene Glycosylation disorder type 2G Genetic Test is conducted in our Genetics test department.

Test Type and Doctor

The COG1 Gene Glycosylation disorder type 2G Genetic Test falls under the category of Metabolic Disorders. It is recommended to consult with a General Physician for this test.

Conclusion

The COG1 Gene Glycosylation disorder type 2G Genetic Test offered by DNA Labs UAE is a valuable tool for diagnosing individuals with suspected glycosylation disorders. It provides important information for genetic counseling and the management of this condition. Additionally, it contributes to ongoing research and the development of potential therapies for glycosylation disorders.

Test Name COG1 Gene Glycosylation disorder type 2G Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COG1 Gene Glycosylation disorder type 2G NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2G
Test Details

COG1 gene glycosylation disorder type 2G NGS genetic test is a type of genetic test that is used to detect mutations or variations in the COG1 gene. This gene is responsible for providing instructions for the production of a protein involved in the process of glycosylation.

Glycosylation is a process in which sugar molecules are attached to proteins or lipids, forming glycoproteins or glycolipids. This process is crucial for the proper functioning of various cellular processes, including cell signaling, protein folding, and cell adhesion.

Mutations in the COG1 gene can disrupt the glycosylation process, leading to a glycosylation disorder known as type 2G. This disorder can result in a wide range of symptoms, including developmental delays, intellectual disabilities, skeletal abnormalities, and organ dysfunction.

The NGS (Next-Generation Sequencing) technique is used in this genetic test to analyze the entire coding region of the COG1 gene. It allows for the simultaneous analysis of multiple genes and can provide a comprehensive evaluation of genetic variations or mutations.

The COG1 gene glycosylation disorder type 2G NGS genetic test can help in diagnosing individuals with suspected glycosylation disorders and can provide valuable information for genetic counseling and management of the condition. It can also aid in understanding the underlying genetic causes of the disorder and contribute to ongoing research and development of potential therapies.